Literature DB >> 6808890

Measurement of the scrapie agent using an incubation time interval assay.

S B Prusiner, S P Cochran, D F Groth, D E Downey, K A Bowman, H M Martinez.   

Abstract

The titer of the scrapie agent was determined by measurements of time intervals from inoculation to onset of illness and from inoculation to death. Both intervals were found to be inversely proportional to the size of the dose injected intracerebrally into random-bred weanling Syrian hamsters. The logarithms of the time intervals minus a time factor were linear functions of the logarithm of the inoculum size. The time factors were determined by regression analysis in order to maximize these linear relationships. An equation relating the titer of the inoculum to the dilution of the sample and the length of the time intervals was developed. This equation facilitates the use of a computerized data base. Validation of these relationships was provided by comparing samples for which the agent was measured both by end-point titration and by time interval assay. Agreement between the two methods was generally within +/-0.5 log10 median infective dose units. No differences between the molecular properties of the agents from hamster and murine sources were observed using primarily the incubation time interval method with the former and end-point titration with the latter. The advantages of this new approach based on time interval measurements are considerable with respect to time and resources.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6808890     DOI: 10.1002/ana.410110406

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  107 in total

1.  Conformation-dependent high-affinity monoclonal antibodies to prion proteins.

Authors:  Larry H Stanker; Ana V Serban; Elisa Cleveland; Robert Hnasko; Azucena Lemus; Jiri Safar; Stephen J DeArmond; Stanley B Prusiner
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

2.  B lymphocyte-restricted expression of prion protein does not enable prion replication in prion protein knockout mice.

Authors:  F Montrasio; A Cozzio; E Flechsig; D Rossi; M A Klein; T Rülicke; A J Raeber; C A Vosshenrich; J Proft; A Aguzzi; C Weissmann
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

3.  Strain-specified relative conformational stability of the scrapie prion protein.

Authors:  D Peretz; M R Scott; D Groth; R A Williamson; D R Burton; F E Cohen; S B Prusiner
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

4.  Theoretical modeling of prion disease incubation.

Authors:  R V Kulkarni; A Slepoy; R R P Singh; D L Cox; F Pázmándi
Journal:  Biophys J       Date:  2003-08       Impact factor: 4.033

5.  Repeated challenge with prion disease: the risk of infection and impact on incubation period.

Authors:  Mike B Gravenor; Nigel Stallard; Robert Curnow; Angela R McLean
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

6.  Lower specific infectivity of protease-resistant prion protein generated in cell-free reactions.

Authors:  Mikael Klingeborn; Brent Race; Kimberly D Meade-White; Bruce Chesebro
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

7.  Conformational transformation and selection of synthetic prion strains.

Authors:  Sina Ghaemmaghami; Joel C Watts; Hoang-Oanh Nguyen; Shigenari Hayashi; Stephen J DeArmond; Stanley B Prusiner
Journal:  J Mol Biol       Date:  2011-08-04       Impact factor: 5.469

Review 8.  A brief history of prions.

Authors:  Mark D Zabel; Crystal Reid
Journal:  Pathog Dis       Date:  2015-10-07       Impact factor: 3.166

9.  Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis.

Authors:  M P McKinley; R K Meyer; L Kenaga; F Rahbar; R Cotter; A Serban; S B Prusiner
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

10.  Prion protein glycosylation is not required for strain-specific neurotropism.

Authors:  Justin R Piro; Brent T Harris; Koren Nishina; Claudio Soto; Rodrigo Morales; Judy R Rees; Surachai Supattapone
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.